SITAJAN MET 50/1000 (Sitagliptin Phosphate 50 mg + Metformin Hydrochloride 1000 mg) 3 × 10 TABLETS.

SITAJAN MET 50/1000 (Sitagliptin Phosphate 50 mg + Metformin Hydrochloride 1000 mg) 3 × 10 TABLETS.
Generic name: Sitagliptin Phosphate and Metformin Hydrochloride.
Brand name: Signature.
Class: Antidiabetic.
Pack size: 30 tablets.
Strength: 50/1000 mg.
Form: Tablets.
Amount: ₦10,600

Description: SITAJAN MET 50/1000 is a combination medication containing Sitagliptin Phosphate and Metformin Hydrochloride. It is used primarily for the management of Type 2 Diabetes Mellitus. This medication works by improving blood sugar control in adults with Type 2 diabetes, particularly when diet and exercise alone do not provide adequate glycaemic control. It is typically prescribed to patients who cannot achieve satisfactory blood glucose levels with metformin alone.

Key features:
• Combines Sitagliptin Phosphate and Metformin Hydrochloride.
• Helps control high blood sugar.
• Used in the management of Type 2 Diabetes Mellitus.
• Often prescribed when metformin alone is not sufficient.

Side effects:
• Common side effects include nausea, vomiting, diarrhoea, stomach upset, headache, and cold-like symptoms (e.g., runny nose, sore throat).

Caution:
• Not recommended for patients with kidney disease, metabolic acidosis, or severe liver impairment.
• Caution in patients with a history of pancreatitis.
• Regular monitoring of kidney function is required.
• Should be taken with meals to reduce gastrointestinal side effects.
• Alcohol consumption should be limited due to an increased risk of lactic acidosis.
• Not for use in Type 1 Diabetes or diabetic ketoacidosis.